Prof C Caldas
Director, Cambridge Breast Cancer Research Unit



  • Professor of Cancer Medicine, University of Cambridge
  • Senior Group Leader, Cancer Research UK Cambridge Research Institute
  • Director, Cambridge Breast Cancer Research Unit
  • Honorary Consultant Medical Oncologist, Addenbrooke’s Hospital


Professor Caldas holds the Chair of Cancer Medicine at the University of Cambridge since 2002. He heads the Breast Cancer Functional Genomics Laboratory at the Cancer Research UK Cambridge Institute. He is an Honorary Consultant Medical Oncologist at Addenbrooke’s Hospital, Lead of the Cambridge Experimental Cancer Medicine Centre, Co-lead of the Cancer Theme at the NIHR Cambridge Biomedical Research Centre, and Director of the Cambridge Breast Cancer Research Unit. He is Fellow of the American College of Physicians, the Royal College of Physicians and the Royal College of Pathologists.  He was elected a Fellow of the Academy of the Medical Sciences in 2004. He was elected a Fellow of the European Academy of Cancer Sciences in 2010. He was selected as a Senior NIHR Investigator in 2012.

Professor Carlos Caldas is a graduate from the University of Lisbon Medical School and trained in Internal Medicine at UT Southwestern, Dallas and Medical Oncology at Johns Hopkins Hospital, Baltimore. He then completed a research fellowship at the Institute of Cancer Research in London. In 1996 he moved to Cambridge where he has directed a research group working on the genetic alterations underlying human epithelial malignancies, with a particular focus on breast cancer.

His current research focus is in the functional genomics of breast cancer and its biological and clinical implications. His main clinical interest is in breast cancer chemotherapy and novel molecularly targeted therapies. He has published over 200 peer-reviewed papers including in Nature, New England Journal of Medicine, Nature Genetics, Nature Medicine, Cell, Cancer Cell, Science Translational Medicine, PNAS, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Genome Biology, PLoS Biology, PLoS Medicine, Lancet Oncology, Breast Cancer Research and Oncogene.